JNJ

PFA to surpass radiofrequency ablation in 2025: Citi survey
Medtech Dive
Tue, 12/17/24 - 12:01 pm
Medtech
pulsed field ablation
radiofrequency ablation
Medtronic
Boston Scientific
JNJ
FDA dents J&J's blockbuster hopes for Rybrevant
Pharmaphorum
Tue, 12/17/24 - 11:53 am
JNJ
Rybrevant
FDA
ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases
Fierce Pharma
Thu, 12/12/24 - 11:44 pm
ICER
drug pricing
Gilead Sciences
JNJ
Novartis
Gilead/Arcellx’s anito-cel’s differentiated safety profile challenges J&J/Legend’s Carvykti
BioSpace
Tue, 12/10/24 - 11:41 am
Gilead Sciences
Arcellx
anito-cel
JNJ
Carvykti
Multiple Myeloma
ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep
Fierce Pharma
Mon, 12/9/24 - 09:10 pm
ASH 2024
GSK
Blenrep
JNJ
Darzalex
Multiple Myeloma
Johnson and Johnson Submits FDA Request for Pediatric Tremfya Approval
Managed Healthcare Executive
Mon, 12/2/24 - 07:17 pm
JNJ
Tremfya
pediatric
psoriasis
juvenile psoriatic arthritis
As J&J tries to wrap up talc litigation in the US, the company now faces class action in UK
Fierce Pharma
Fri, 11/22/24 - 11:51 am
JNJ
legal
UK
Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll
Fierce Pharma
Wed, 11/20/24 - 08:41 pm
JNJ
Merck
China
layoffs
Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tue, 11/19/24 - 11:22 am
prostate cancer
clinical trials
Candel Therapeutics
ProstAtak
JNJ
Akeega
Pfizer
Mevrometostat
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Clinical Trials Arena
Tue, 11/19/24 - 11:00 am
JNJ
clinical trials
JNJ-2113
psoriasis
J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial
Clinical Trials Arena
Fri, 11/15/24 - 11:02 am
JNJ
nipocalimab
Sjögren’s syndrome
Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court
MedCity News
Wed, 11/13/24 - 09:48 pm
JNJ
340B
legal
drug rebates
J&J Brings Ottava into the Forefront of Surgical Robotics with New IDE Approval
Medical Devices and Diagnostics Industry
Tue, 11/12/24 - 08:41 pm
JNJ
Medtech
robotic surgery
Ottava
Spravato is just the beginning in a new wave of depression meds
Pharma Voice
Mon, 11/11/24 - 11:26 am
JNJ
Spravato
depression
drug development
J&J angles Darzalex for first move into early-stage myeloma with trial win, FDA filing
Fierce Pharma
Fri, 11/8/24 - 11:52 am
JNJ
Darzalex
Multiple Myeloma
FDA
J&J Joins Medtronic & Boston Sci in PFA Race with FDA Approval of Varipulse
Medical Devices and Diagnostics Industry
Fri, 11/8/24 - 12:03 am
Medtech
JNJ
Varipulse
FDA
atrial fibrillation
Medtronic
Boston Scientific
J&J’s Shockwave deal pays off as IVL catheter meets primary endpoint in trial
Clinical Trials Arena
Tue, 11/5/24 - 11:16 am
Medtech
JNJ
Shockwave Medical
IVL catheters
Javelin
peripheral artery disease
Pharmas ask appeals court to reconsider IRA lawsuits
Pharmaphorum
Mon, 11/4/24 - 11:08 am
Inflation Reduction Act
legal
drug pricing
JNJ
Bristol Myers Squibb
AstraZeneca
Big Pharma earnings hang hope on the next generation of blockbusters
Pharma Voice
Thu, 10/31/24 - 09:19 am
Pfizer
JNJ
Biogen
Novartis
earnings
Dueling IL-23 data drop as Lilly, J&J await FDA decisions in Crohn's
First Word Pharma
Mon, 10/28/24 - 06:24 pm
Eli Lilly
JNJ
Crohn's Disease
FDA
clinical trials
Tremfya
Omvoh

Pages